Zyloprim is a brand name of allopurinol, approved by the FDA in the following formulation(s):
ZYLOPRIM (allopurinol - tablet; oral)
Manufacturer: PROMETHEUS LABS
Approved Prior to Jan 1, 1982
Strength(s): 100MG [AB], 300MG [RLD][AB]
Has a generic version of Zyloprim been approved?
Yes. The following products are equivalent to Zyloprim:
allopurinol tablet; oral
Manufacturer: APOTEX INC
Approval date: September 8, 2005
Strength(s): 100MG [AB], 300MG [AB]
Manufacturer: CARACO
Approval date: August 30, 2007
Strength(s): 100MG [AB], 300MG [AB]
Manufacturer: IPCA LABS LTD
Approval date: March 16, 2011
Strength(s): 100MG [AB], 300MG [AB]
Manufacturer: MUTUAL PHARM
Approval date: January 9, 1987
Strength(s): 100MG [AB], 300MG [AB]
Manufacturer: MYLAN
Approval date: October 24, 1986
Strength(s): 100MG [AB], 300MG [AB]
Manufacturer: NORTHSTAR HLTHCARE
Approval date: September 11, 2007
Strength(s): 100MG [AB], 300MG [AB]
Manufacturer: VINTAGE PHARMS
Approval date: June 27, 2003
Strength(s): 100MG [AB], 300MG [AB]
Manufacturer: WATSON LABS
Approval date: September 28, 1984
Strength(s): 100MG [AB], 300MG [AB]
LOPURIN (allopurinol tablet; oral)
Manufacturer: DR REDDYS LA
Approval date: April 2, 1987
Strength(s): 100MG [AB], 300MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zyloprim. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Zyloprim.
See also...
- Zyloprim Consumer Information (Wolters Kluwer)
- Zyloprim Consumer Information (Cerner Multum)
- Allopurinol Consumer Information (Drugs.com)
- Allopurinol Consumer Information (Wolters Kluwer)
- Allopurinol Consumer Information (Cerner Multum)
- Allopurinol Intravenous Advanced Consumer Information (Micromedex)
- Allopurinol AHFS DI Monographs (ASHP)
No comments:
Post a Comment